Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide for Chronic Central Serous Chorioretinopathy
NCT03542006Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jun 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of brinzolamide in Central Serous Chorioretinopathy (CSCR), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
brinzolamide
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT03542006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542006.